Le Lézard
Classified in: Health
Subjects: TRI, FDA

Colibrítm, COPAN's Automated Specimen Workup Instrument, Receives FDA 510(k) Clearance for use with bioMérieux VITEK® 2 Antimicrobial Susceptibility Testing (AST) System


MURRIETA, Calif., Oct. 10, 2022 /PRNewswire/ -- COPAN Diagnostics Inc. is proud to announce the second FDA clearance of Colibrítm, a semi-automated pre-analytical processor that is a complementary part of WASPLab®, COPAN's full laboratory automation system.

COPAN announces FDA clearance of Colibrítm to automatically prepare McFarland AST suspensions & MALDI-TOF ID targets

Colibrítm system is an in vitro fully automated specimen workup platform designed to prepare MALDI-TOF ID targets and create bacterial suspensions for antibiotic susceptibility testing (AST). It comprises of Colibrítm Vision System and Colibrítm Preparation Station. This new Colibrítm 510(k) clearance announcement is exciting because it substantiates that fully automated culture workup for ID and AST is possible. "COPAN is committed to continue to expand the capabilities of Colibrítm to manage other AST platforms and the Company continues to innovate to remain at the leading edge of automation for clinical microbiology," stated Norman Sharples, COPAN Diagnostics' CEO and Co-Founder.

In December 2021, COPAN announced the FDA 510(k) clearance of Colibrítm for use with MALDI-TOF MS analyzers. This same instrument has now received its second FDA 510(k) clearance for the preparation of microbial suspensions for AST with bioMérieux VITEK 2, making Colibrítm the first instrument in its class to receive 510(k) clearance for simultaneous preparation of MALDI-TOF slides and McFarland AST suspensions.

"Clinical microbiology is facing tremendous challenges, including labor shortages, dramatically increased workloads, pressure for on-demand testing, and rapid turnaround times for results. The FDA clearance of COPAN's Colibrítm for MALDI and now Vitek 2 will save time and labor by automating crucial steps in diagnostic microbiology. When used with COPAN's advanced AI software, the laboratory has total traceability and precision regarding colony selection and transfer to MALDI-TOF target slides and now AST tube preparation. Complex tasks that occur tens of thousands of times per day in microbiology laboratories require great care and attention. Such tasks are now fully automated with unquestionable accuracy. With these critical processes in laboratory workup automated and interfaced with downstream mass spectrometry instruments and Vitek 2, experienced laboratory professionals may now use their time to perform other complex tasks requiring their unique skills and expertise," added Sharples.

The Colibrítm system, paired with Copan's revolutionary artificial intelligence (AI) software, PhenoMATRIX®Elite with TAG, offers clinical Microbiology laboratories cutting-edge, intelligence-driven solutions for specimen workup to help streamline workflow and address the most challenging demands in the laboratory. "COPAN continues to develop robotic and AI-driven solutions for clinical laboratories as our commitment to innovating together is the heart of our Company," concluded Sharples.

About Colibrítm

COPAN's Colibrítm automatically picks isolated colonies for further workup and investigations. Colonies are designated by the laboratory technologist or automatically by COPAN's advanced AI, PhenoMATRIX® TAG. The precision robotics of full laboratory automation system WASPLab® combined with Colibrítm help to eliminate any transposition errors.

Colibrítm works with both bioMérieux VITEK® MS and Bruker Biotyper systems, seeding either manufacturers' target plate formats, automatically applying matrix, and automatically sends instructions and coordinates identifying each culture workup spot.

Colibrítm seeds colonies into various-size tubes to prepare McFarland suspensions for AST. The system is now FDA cleared for the preparation of microbial suspensions for AST with bioMérieux VITEK 2.

About PhenoMATRIXtm

PhenoMATRIX® is an unparalleled AI-powered software suite that uses an advanced selection of highly sophisticated algorithms which gives users of COPAN's full laboratory automation WASPLab® the power to automatically pre-assess, pre-sort and segregate bacterial cultures. PhenoMATRIX® allows laboratories to quickly view and discard up to 80% of negative cultures with the click of a button. 

PhenoMATRIX® TAG is the latest evolution of COPAN's advanced AI to detects and "tags" the best colonies to be picked by Colibrítm for workup. The PhenoMATRIX® TAG software highlights isolated and aggregated colonies. After defining the optimal colonies for selection, PhenoMATRIX® TAG communicates the colony coordinates to the Colibrítm for reliable and accurate picking.

About COPAN Full Laboratory Automation WASPLab®

WASPLab® is a highly efficient, modular, scalable, and customizable specimen processing and culture workup system for clinical microbiology. Samples move from front-end processing to smart incubation, digital microbiology, and artificial intelligence for plate reading. 

About COPAN Diagnostics, Inc.

COPAN Diagnostics is part of COPAN Group, a leading manufacturer of collection and transport systems and full laboratory automation in the world. With a reputation for innovation, COPAN's collaborative approach to pre-analytics has resulted in FLOQSwabs®, ESwabtm, UTM Universal Transport Medium®, laboratory automation including WASP® and WASPLab® and Microbiology laboratory artificial intelligence software PhenoMATRIX®. For more information, visit www.copanusa.com

SOURCE COPAN Diagnostics, Inc.


These press releases may also interest you

at 16:58
TIME has named Yale School of Medicine immunobiologist Dr. Akiko Iwasaki to the 2024 TIME100 Health, the magazine's annual list of the 100 most influential people in global health care. She was also named last week to the TIME100, TIME's list of the...

at 16:56
Premia Spine, a leader in innovative spinal treatment solutions, today announced that the pioneering study titled "Lumbar Facet Arthroplasty for...

at 16:36
Richards Packaging Income Fund (the "Fund") announced that the five nominees listed in the management information circular for the 2024 Annual Meeting of Unitholders were elected as Trustees of the Fund at the annual general meeting held in Toronto,...

at 16:34
An Illinois utility watchdog group has joined forces with a community that has had highly publicized problems with lead in its drinking water to file testimony arguing that Aqua Illinois' proposed $19.2 million rate hike should be slashed by at least...

at 16:30
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data highlight multiple ascending dose safety, bioactivity...

at 16:30
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased...



News published on and distributed by: